Actively Recruiting
Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women At Higher Risk
Led by London School of Hygiene and Tropical Medicine · Updated on 2025-03-11
30000
Participants Needed
1
Research Sites
71 weeks
Total Duration
On this page
Sponsors
L
London School of Hygiene and Tropical Medicine
Lead Sponsor
U
UNITAID
Collaborating Sponsor
AI-Summary
What this Trial Is About
Heavy bleeding after childbirth, known as a postpartum haemorrhage (PPH), causes about 70,000 maternal deaths every year. Tranexamic acid (TXA) is a lifesaving treatment for women with PPH. The I'M WOMAN trial is a research study to see whether giving TXA just before childbirth will stop women developing PPH. The trial will assess the effects of intramuscular (IM) and intravenous (IV) tranexamic acid on PPH, side effects and other important maternal health outcomes.
CONDITIONS
Official Title
Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women At Higher Risk
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 years or older admitted to hospital to give birth vaginally or by caesarean section
- Presence of one or more known risk factors for postpartum haemorrhage
You will not qualify if you...
- Women with a clear indication for tranexamic acid treatment
- Women with a clear contraindication for tranexamic acid
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mbeya Regional Referral Hospital
Mbeya, Tanzania
Actively Recruiting
Research Team
A
Amy Brenner
CONTACT
I
Ian Roberts
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here